Sotera Health Company Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,164	1,100	1,049	1,004	931.48
Revenue Growth (YoY)	5.74%	4.88%	4.54%	7.75%	13.85%
Cost of Revenue	518.08	498.15	472.13	446.68	412.81
Gross Profit	645.53	602.3	577.16	557	518.67
Selling, General & Admin	252.76	204.75	186.37	166.18	149.36
Amortization of Goodwill & Intangibles	30.74	62.04	63.8	62.94	63.78
Operating Expenses	283.5	266.79	250.16	229.12	213.14
Operating Income	362.03	335.51	326.99	327.89	305.53
Interest Expense	-155.72	-164.69	-142.88	-80.14	-74.19
Currency Exchange Gain (Loss)	-0.95	-0.2	-0.16	-0.15	-1.35
Other Non Operating Income (Expenses)	8.55	0.12	2.38	-0.46	3.56
EBT Excluding Unusual Items	213.91	170.74	186.34	247.14	233.55
Gain (Loss) on Sale of Investments	-	-	-	-9.61	-
Legal Settlements	-64.94	-32.69	-80.31	-480.64	-45.66
Other Unusual Items	-1.46	-24.17	-	-	-15.58
Pretax Income	147.51	113.87	106.03	-243.11	175.72
Income Tax Expense	69.56	69.48	54.65	-9.54	58.6
Earnings From Continuing Operations	77.95	44.4	51.38	-233.57	117.12
Minority Interest in Earnings	-	-	-	-	-0.24
Net Income	77.95	44.4	51.38	-233.57	116.88
Preferred Dividends & Other Adjustments	-	0.06	0.29	-	1.52
Net Income to Common	77.95	44.34	51.09	-233.57	115.36
Net Income Growth	75.57%	-13.58%	-	-	-
Shares Outstanding (Basic)	284	283	281	280	279
Shares Outstanding (Diluted)	286	285	283	280	279
Shares Change (YoY)	0.53%	0.60%	1.12%	0.26%	17.54%
EPS (Basic)	0.27	0.16	0.18	-0.83	0.41
EPS (Diluted)	0.27	0.16	0.18	-0.83	0.41
EPS Growth	72.20%	-12.89%	-	-	-
Free Cash Flow	149.18	45.09	-362.71	95.58	179.38
Free Cash Flow Per Share	0.52	0.16	-1.28	0.34	0.64
Gross Margin	55.48%	54.73%	55.01%	55.50%	55.68%
Operating Margin	31.11%	30.49%	31.16%	32.67%	32.80%
Profit Margin	6.70%	4.03%	4.87%	-23.27%	12.38%
Free Cash Flow Margin	12.82%	4.10%	-34.57%	9.52%	19.26%
EBITDA	498.46	501.78	487.33	475.63	458.68
EBITDA Margin	42.84%	45.60%	46.44%	47.39%	49.24%
D&A For EBITDA	136.43	166.28	160.34	147.75	153.15
EBIT	362.03	335.51	326.99	327.89	305.53
EBIT Margin	31.11%	30.49%	31.16%	32.67%	32.80%
Effective Tax Rate	47.16%	61.01%	51.54%	-	33.35%
Revenue as Reported	1,164	1,100	1,049	1,004	931.48

Updated Feb 24, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q